Psychedelic drug developer Psyence Group Inc. (CSE: PSYG) saw a mixed bag in its quarterly report ending Dec. 31, 2023, turning a profit despite no revenue coming in. The firm is fixed on streamlining operations and honing in on its key growth areas, but a financial review shows an ongoing …
Tag: Investing
New York Governor calls on Google, Yelp to stop listing unlicensed stores
New York State Governor Kathy Hochul on Wednesday called out social media companies for helping to promote unlicensed stores and New York legislators for not allowing more strict enforcement. Hochul was joined by social justice dispensary owners as she addressed the proliferation of unlicensed stores in the state. She noted …
Psilocybin treatment beats placebo in Incannex anxiety study
New-York based Incannex Healthcare Inc. (Nasdaq: IXHL) reported positive results from its Phase 2 Psi-GAD1 clinical trial assessing the effectiveness of psilocybin in treating generalized anxiety disorder (GAD). The trial, conducted in partnership with Monash University’s Clinical Psychedelic Lab and led by Dr. Paul Liknaitzky, looked to evaluate the efficacy …
The Daily Hit: February 27, 2024
The Daily Hit is a recap of the top financial news stories for Feb. 27, 2024. On the Site Northern California cannabis company sues city, alleges corruption in licensing process A small marijuana retail chain in Northern California has filed suit against the town of Healdsburg and its city council, …